Six readers
| reader | found | score |
|---|---|---|
| genetics Open Targets | no genetic evidence; overall 0.10 from other evidence | 0.00 |
| cell type Human Protein Atlas | expressed broadly, no clear home in brain cells | 0.40 |
| chemistry Open Targets | a small-molecule pocket | 0.60 |
| trials ClinicalTrials.gov | 1 Parkinson's trial, 0 stopped | 1.00 |
| literature PubMed | 93 Parkinson's papers of 2,583 | 0.40 |
| pathways Reactome | 21 pathways; mostly lysosome and autophagy | 1.00 |
No case: the score is under the bar. Receipt 2674
Sealed predictions
- VCP in dopamine neurons, braak-0.37 (p 0.329) → +0.01 (p 0.982)receipt 2680
Swarm cases
receipt 2680: VCP in dopamine neurons, braak
- power
- full sample -0.09 (p 0.709, n 18), 95% CI -0.54 to +0.39. the interval is wide: not enough donors to tell.
- confounder
- adjusted for sex: -0.16 (p 0.532, n 18). does not hold up.
- composition
- dopamine neurons share of nuclei vs axis +0.05 (p 0.854); controlling for it: -0.05 (p 0.840, n 18). could be the mix.
- skeptic
- leave-one-out range -0.21 to +0.06, sign flips 3; without severely affected donors -0.09 (p 0.709, n 18). fragile.
- cell type
- no other cell group does better.
- axis
- no measure beats "tracks Braak Lewy-body stage" for VCP in dopamine neurons.
case closed: nothing better to follow up.
Receipts
loading the receipts